PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 1:52 AM ET

Sponsor Check › Person

Robert W. Croce

Related person on Form D filings · address states as listed: CA, FL, MD, NJ · listed Jul 28, 2009 → Nov 24, 2021

12issuers
61Form D filings
2009–2021years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

2 of 46 offerings report sales commissions totalling $1,180,000; 0 report finder's fees; 4 report proceeds to related persons totalling $3,114,642. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Mar 4, 2022 D
File 021-435950
$0$0$0None listed on this filing
EDGAR ↗Nov 24, 2021 D/A
File 021-372142
$0$0$0None listed on this filing
EDGAR ↗Aug 27, 2021 D
File 021-411490
$0$0$0None listed on this filing
EDGAR ↗Jul 6, 2021 D
File 021-405300
$0$0$0None listed on this filing
EDGAR ↗May 6, 2021 D
File 021-398487
$0 (est.)$0 (est.)$0 (est.)None listed on this filing
EDGAR ↗Oct 1, 2020 D
File 021-376907
$0$0$0None listed on this filing
EDGAR ↗Nov 21, 2019 D
File 021-353952
$0$0$0None listed on this filing
EDGAR ↗Aug 15, 2019 D
File 021-346616
$0$0$0None listed on this filing
EDGAR ↗Dec 28, 2018 D
File 021-329171
$0$0$0None listed on this filing
EDGAR ↗Oct 12, 2018 D
File 021-323465
$0$0$0None listed on this filing
EDGAR ↗May 31, 2018 D
File 021-313621
$0$0$0None listed on this filing
EDGAR ↗May 24, 2018 D
File 021-313186
$0$0$0None listed on this filing
EDGAR ↗Dec 12, 2017 D
File 021-300471
$0$0$0None listed on this filing
EDGAR ↗Nov 21, 2017 D
File 021-299301
$0 (est.)$0$0 (est.)None listed on this filing
EDGAR ↗Nov 15, 2017 D
File 021-298843
$0$0$0None listed on this filing
EDGAR ↗Jul 10, 2017 D/A
File 021-267790
$0 (est.)$0$0 (est.)None listed on this filing
EDGAR ↗May 25, 2017 D/A
File 021-265112
$0$0$0None listed on this filing
EDGAR ↗Mar 31, 2017 D
File 021-283747
$0$0$0None listed on this filing
EDGAR ↗Jan 6, 2017 D
File 021-277831
$0$0$0None listed on this filing
EDGAR ↗Dec 30, 2016 D/A
File 021-234314
$0$0$0None listed on this filing
EDGAR ↗Jul 27, 2016 D/A
File 021-206072
$430,000 (est.)$0$1,360,000 (est.)Piper Jaffray & Co. BrokerCheck CRD 655 ↗
EDGAR ↗May 5, 2015 D
File 021-239193
$0$0$0None listed on this filing
EDGAR ↗Mar 9, 2015 D/A
File 021-232596
$0$0$0None listed on this filing
EDGAR ↗Jan 28, 2014 D/A
File 021-178788
$0$0$0None listed on this filing
EDGAR ↗Nov 18, 2013 D
File 021-206492
$0$0$0None listed on this filing
EDGAR ↗Jul 12, 2013 D/A
File 021-181224
$750,000 (est.)$0$0ROBERTS MITANI, LLC BrokerCheck CRD 30022 ↗
EDGAR ↗Jun 4, 2013 D/A
File 021-195730
$0$0$229,642 (est.)None listed on this filing
EDGAR ↗Jun 22, 2012 D
File 021-180202
$0$0$0None listed on this filing
EDGAR ↗Jun 21, 2012 D
File 021-180116
$0$0$800,000 (est.)None listed on this filing
EDGAR ↗May 22, 2012 D
File 021-178652
$0$0$0None listed on this filing
EDGAR ↗Dec 14, 2011 D
File 021-170051
$0$0$0 (est.)None listed on this filing
EDGAR ↗Dec 5, 2011 D/A
File 021-160894
$0$0$0None listed on this filing
EDGAR ↗Nov 25, 2011 D
File 021-169229
$0$0$0None listed on this filing
EDGAR ↗Jul 15, 2011 D/A
File 021-149681
$0$0$725,000 (est.)None listed on this filing
EDGAR ↗Jun 14, 2011 D
File 021-161241
$0$0$0 (est.)None listed on this filing
EDGAR ↗Jun 6, 2011 D
File 021-160812
$0$0$0None listed on this filing
EDGAR ↗May 16, 2011 D
File 021-159861
$0$0$0None listed on this filing
EDGAR ↗Apr 25, 2011 D
File 021-158825
$0$0$0None listed on this filing
EDGAR ↗Apr 25, 2011 D
File 021-158826
$0$0$0None listed on this filing
EDGAR ↗Apr 25, 2011 D
File 021-158827
$0$0$0None listed on this filing
EDGAR ↗Feb 4, 2011 D
File 021-154828
$0$0$0None listed on this filing
EDGAR ↗Apr 28, 2010 D
File 021-141256
$0$0$0None listed on this filing
EDGAR ↗Mar 16, 2010 D/A
File 021-102229
$0$0$0None listed on this filing
EDGAR ↗Oct 26, 2009 D/A
File 021-87399
$0$0$0None listed on this filing
EDGAR ↗Aug 14, 2009 D
File 021-117353
$0$0$0None listed on this filing
EDGAR ↗Apr 27, 2009 D
File 021-87118
$0$0$0None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorMar 4, 2022D$25,213,472
similar: $2,000,000–$19,999,994
$23,963,44254
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Revelle Aesthetics, Inc.
group: Exploramed
DirectorNov 24, 2021D/A$49,999,996
similar: $829,831–$9,999,998
$49,999,85536
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorAug 27, 2021D$4,000,000
similar: $2,000,000–$19,999,994
$3,748,71296
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ANCORA HEART, INC.DirectorJul 6, 2021D$80,000,000
similar: $829,831–$9,999,998
$80,000,00047
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorMay 6, 2021D$10,845,671
similar: $2,000,000–$19,999,994
$5,445,36317
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Willow Innovations, Inc.DirectorOct 1, 2020D$45,169,431
similar: $829,831–$9,999,998
$32,512,38835
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Revelle Aesthetics, Inc.
group: Exploramed
DirectorJul 30, 2020D$49,999,996
similar: $829,831–$9,999,998
$24,999,9963
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorNov 21, 2019D$14,765,000
similar: $2,000,000–$19,999,994
$7,382,50039
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Willow Innovations, Inc.DirectorAug 15, 2019D$29,478,861
similar: $829,831–$9,999,998
$22,696,9127
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗ANCORA HEART, INC.DirectorDec 28, 2018D$35,000,000
similar: $829,831–$9,999,998
$23,460,2565
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorOct 12, 2018D$21,100,000
similar: $2,000,000–$19,999,994
$12,360,00029
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ANCORA HEART, INC.DirectorMay 31, 2018D$30,000,001
similar: $829,831–$9,999,998
$17,839,84432
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Earlens CorpDirectorMay 24, 2018D$20,000,000
similar: $829,831–$9,999,998
$9,006,37821
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Willow Innovations, Inc.DirectorDec 12, 2017D$31,189,200
similar: $829,831–$9,999,998
$27,470,20412
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorNov 21, 2017D$52,000,000
similar: $2,000,000–$19,999,994
$3,000,00010
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ExploraMed V, L.L.C.
group: Exploramed
DirectorNov 15, 2017D$8,756,650
similar: $829,831–$9,999,998
$8,756,65028
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorJul 10, 2017D/A$15,000,000
similar: $2,000,000–$19,999,994
$12,300,0009
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Earlens CorpDirectorMay 25, 2017D/A$77,274,197
similar: $829,831–$9,999,998
$72,121,79159
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Moximed, IncDirectorMar 31, 2017D$51,450,000
similar: $829,831–$9,999,998
$49,541,7208
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗NEOTRACT INCDirectorJan 6, 2017D$14,999,999
similar: $829,831–$9,999,998
$12,816,96712
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorDec 30, 2016D/A$31,000,000
similar: $2,000,000–$19,999,994
$31,000,00033
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorJul 27, 2016D$10,000,000
similar: $2,000,000–$19,999,994
$4,000,0004
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorJul 27, 2016D/A$50,796,673
similar: $2,000,000–$19,999,994
$50,402,46739
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Earlens CorpDirectorJun 15, 2016D$69,029,068
similar: $829,831–$9,999,998
$53,593,01022
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCExecutive Officer, DirectorFeb 22, 2016D/A$46,636,324
similar: $2,000,000–$19,999,994
$44,402,46737
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Moximed, IncDirectorMay 5, 2015D$37,642,028
similar: $829,831–$9,999,998
$19,742,755104
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorMar 18, 2015D/A$42,736,324
similar: $2,000,000–$19,999,994
$38,008,32430
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Willow Innovations, Inc.DirectorMar 9, 2015D/A$17,500,000
similar: $829,831–$9,999,998
$17,410,00043
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorFeb 19, 2015D$27,000,000
similar: $2,000,000–$19,999,994
$16,200,00030
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Willow Innovations, Inc.DirectorJan 21, 2015D$16,000,000
similar: $829,831–$9,999,998
$15,000,0005
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorMar 12, 2014D/A$26,636,324
similar: $2,000,000–$19,999,994
$26,636,32427
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗NEOTRACT INCDirectorJan 28, 2014D/A$56,700,000
similar: $829,831–$9,999,998
$50,556,68471
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗ARSTASIS INCDirectorNov 18, 2013D$18,999,998
similar: $829,831–$9,999,998
$16,499,9982
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorNov 8, 2013D$21,637,118
similar: $2,000,000–$19,999,994
$17,931,35426
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorJul 12, 2013D/A$14,999,994$5,195,22611No minimum reported
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorJun 4, 2013D/A$5,470,329$4,307,8847No minimum reported
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorApr 29, 2013D$3,000,000$1,809,5553No minimum reported
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorJul 13, 2012D$14,999,994$2,499,9991No minimum reported
EDGAR ↗ARSTASIS INCDirectorJun 22, 2012D$51,179,299$37,837,30514No minimum reported
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorJun 21, 2012D$7,000,000$5,000,00013No minimum reported
EDGAR ↗NEOTRACT INCDirectorMay 24, 2012D$40,320,000$32,399,99512$1
EDGAR ↗Vibrynt, INcDirectorMay 22, 2012D$5,500,000$2,750,0005$1
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorDec 14, 2011D$35,000,000$18,784,66622No minimum reported
EDGAR ↗Moximed, IncDirectorDec 5, 2011D/A$45,862,892$45,837,65655$1
EDGAR ↗ExploraMed IV, L.L.C.
group: Exploramed
DirectorNov 25, 2011D$8,000,000$6,600,0001$1
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorJul 15, 2011D/A$12,000,000$9,694,40022No minimum reported
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorJun 14, 2011D$5,000,000$3,159,32530No minimum reported
EDGAR ↗Moximed, IncDirectorJun 7, 2011D$45,300,000$43,269,6566$2
EDGAR ↗ARSTASIS INCDirectorJun 6, 2011D$25,521,743$25,521,74312No minimum reported
EDGAR ↗Vibrynt, INcDirectorMay 16, 2011D$11,500,000$11,500,0005$1
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorApr 25, 2011D$1,375,000$1,375,00022No minimum reported
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorApr 25, 2011D$348,000$348,00016No minimum reported
EDGAR ↗VASCULAR THERAPIES INC
group: Vascular
DirectorApr 25, 2011D$646,340$646,34023No minimum reported
EDGAR ↗NEOTRACT INCDirectorFeb 4, 2011D$27,331,840$25,999,9995$1
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorOct 27, 2010D$6,000,000$4,492,70014No minimum reported
EDGAR ↗ANCORA HEART, INC.DirectorApr 28, 2010D$29,999,998$29,999,9981No minimum reported
EDGAR ↗SVELTE MEDICAL SYSTEMS INCDirectorMar 16, 2010D/A$10,000,000$4,151,04322No minimum reported
EDGAR ↗NEOTRACT INCDirectorOct 26, 2009D/A$30,240,000$28,108,16015$1
EDGAR ↗Moximed, IncDirectorAug 14, 2009D$11,000,000$10,000,0002$2
EDGAR ↗NEOTRACT INCDirectorJul 28, 2009D$25,200,000$23,733,0443$1
EDGAR ↗ARSTASIS INCDirectorApr 27, 2009D$22,400,005$22,400,00513$11

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Robert W. Croce. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Joshua Makower — 22 shared filings (7 issuers) · roles as listed: Director, Executive Officer · also listed on 9 other issuers
  • Robert Flanagan — 22 shared filings (2 issuers) · role as listed: Director · also listed on 2 other issuers
  • Ryan Drant — 18 shared filings (6 issuers) · role as listed: Director · also listed on 32 other issuers
  • Phillip D. Torrence — 15 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 4 other issuers
  • Mark A. Kielek — 15 shared filings (1 issuer) · role as listed: Executive Officer
  • Somu Subramaniam — 13 shared filings (2 issuers) · role as listed: Director · also listed on 2 other issuers
  • Gerald Dorros — 12 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Sriram Iyer — 12 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • John Nehra — 11 shared filings (4 issuers) · role as listed: Director · also listed on 12 other issuers
  • Jack Darby — 11 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Robert Anderson — 10 shared filings (6 issuers) · role as listed: Director · also listed on 11 other issuers
  • Mark Pomeranz — 9 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Henry A. Plain, Jr. — 8 shared filings (2 issuers) · role as listed: Director · also listed on 12 other issuers
  • David C. Auth — 8 shared filings (2 issuers) · role as listed: Director · also listed on 3 other issuers
  • Lewis Pell — 8 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 3 other issuers
  • Michael Bamberger — 8 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Allan Tessler — 8 shared filings (1 issuer) · role as listed: Director
  • Tim A. Fischell — 7 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 4 other issuers
  • Robert E. Fischell — 7 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 7 other issuers
  • Mina Sooch — 7 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers
  • David R. Fischell — 7 shared filings (1 issuer) · role as listed: Director · also listed on 7 other issuers
  • Richard Dakers — 7 shared filings (1 issuer) · role as listed: Director
  • Robert K. Anderson — 7 shared filings (3 issuers) · role as listed: Director · also listed on 1 other issuer
  • Andrew Midler — 7 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • William Facteau — 6 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 3 other issuers
  • Richard T. Spencer — 6 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Kiyoshi Takesue — 6 shared filings (1 issuer) · role as listed: Director
  • Nina Richardson — 6 shared filings (3 issuers) · role as listed: Director · also listed on 1 other issuer
  • Theodore Lamson — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Kevin Sidow — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 6 other issuers
  • David Amerson — 5 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 3 other issuers
  • Michael Carusi — 5 shared filings (1 issuer) · role as listed: Director · also listed on 16 other issuers
  • Glen Nelson — 5 shared filings (2 issuers) · role as listed: Director · also listed on 4 other issuers
  • Bruce Modesitt — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Niel F. Starksen — 4 shared filings (2 issuers) · roles as listed: Director, Executive Officer
  • Maria Sainz — 4 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Michael Johnson — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Kadir Kadhiresan — 4 shared filings (1 issuer) · role as listed: Director · also listed on 7 other issuers
  • Paul Barkofsky — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Samuel M. Liang — 4 shared filings (1 issuer) · role as listed: Director

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert W. Croce appears on a new Form D, or when a court case or SEC action is matched to them. See plans →